Some cancer patients could avoid surgery with innovative new therapy

Some cancer patients could avoid surgery with innovative new therapy

NEWYou can now listen to Fox News articles! An experimental drug has shown promise in fighting a hard-to-treat form of bladder cancer known as BCG-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC). BCG (Bacillus Calmette-Guérin) is an immunotherapy drug that is often the first-line treatment for certain early-stage bladder cancers. The new drug, TAR-200 — which was…

Read More